FN1 and pulmonary fibrosis: Importantly, there was no significant difference in pulmonary fibrosis, as assessed by either the modified Ashcroft score (Figure 3a) or reverse transcriptase PCR analysis of fibrotic markers collagen 1 and fibronectin (Figure S1A,B), between bleomycin‐treated groups (Figure 3b).